Support for endoxifen GEL clinical development
Ended Awarded Last action
- Contract number
- HHSN26100002
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,181,806
Award facts
- Opportunity
-
- N01CN4500945 Solicitation number
- Preclinical PREVENT Cancer Program- Toxicology and Pharmacology Testing Award Notice · Posted Sep 26, 2015
- Contract value 94% obligated
-
- $1,181,805.78 Current, with exercised options
- $1,259,678.78 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$400,017 | |
| Funding Only Action | -$124,892 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $174,815 | |
| Other Administrative Action | $0 | |
| Original award | $1,531,900 |
About this award
This is a delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The $1,259,678.78 contract is to provide support for the preclinical development of an endoxifen gel, including pharmacology, toxicology, and safety studies to support an Investigational New Drug (IND) application. This contract is part of the NCI's PREVENT Cancer Preclinical Drug Development Program, a $150 million multiple-award IDIQ contract vehicle that enables the agency to efficiently access IITRI's preclinical research capabilities. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 19, 2016.
How much is contract HHSN26100002 worth?
The government has obligated $1,181,806 on HHSN26100002. Its potential value, with all options, is $1,259,679.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a delivery order under HHSN261201500024I, an indefinite delivery contract, on PREVENT Toxicology and Pharmacology Testing (PREVENT TOX).
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award